Gelesis reports fourth quarter and full year 2022 results

Boston--(business wire)---- $gls #earnings--gelesis holdings, inc. (nyse: gls) (“gelesis” or the “company”), the maker of plenity for weight management, today reported financial results for the year ended december 31, 2022. plenity is a novel orally administered, fda-cleared weight management therapy that helps people feel satisfied with smaller portions, so they can eat less and lose weight, while still enjoying the foods they love.
GLS Ratings Summary
GLS Quant Ranking